Abstract. The purpose of this study was to determine the immunophenotype and histologic classification of 50 cases of feline gastrointestinal lymphoma. Classification was determined using the National Cancer Institute Working Formulation and the Revised European and American Lymphoma/ World Health Organization classification system. Tissue sections were stained with HE, phosphotungstic acid hematoxylin, anti-CD3, anti-CD79a, and anti-BLA.36. Overall, B-cell tumors predominated at 54% (27/50), including 16 diffuse large with immunoblastic nuclear type, 2 diffuse large with centroblastic nuclear type, 3 small lymphocytic, 4 lymphocytic intermediate type, and 2 T-cell-rich large B-cell lymphomas. T-cell tumors comprised 38% (19/50), including 15 epitheliotropic small lymphocytic and 4 lymphoblastic. Three tumors (6%) were nonreactive for B-and T-cell markers and had eosinophilic cytoplasmic granules when stained with HE. Gastric tumors were diagnosed in 24% (12/50) of cats, and 18% (9/50) were present only in the stomach. All gastric lymphomas were of B-cell lineage. Small intestinal lymphoma predominated, with 74% (37/50) of cats affected: T-cell tumors comprised 52% (19/ 37); 38% (14/37) were B-cell tumors; 8% (3/37) were nonreactive for B-and T-cell markers; and 2% (1/37) expressed both CD3 and BLA.36. Of the 8 cats (16%) that had lymphoma of the large intestine, 88% (7/ 8) had B-cell tumors and 12% (1/8) had T-cell tumors. The strongest association between gastrointestinal lymphoma immunophenotype, histologic classification, and location occurred in the stomach, where there was a predominance of diffuse large B-cell lymphoma of immunoblastic nuclear type.
BackgroundThis study evaluated the exposure of dogs to three different Ehrlichia spp. in the south and central regions of the United States where vector-borne disease prevalence has been previously difficult to ascertain, particularly beyond the metropolitan areas.MethodsDog blood samples (n = 8,662) were submitted from 14 veterinary colleges, 6 private veterinary practices and 4 diagnostic laboratories across this region. Samples were tested for E. canis, E. chaffeensis and E. ewingii specific antibodies using peptide microtiter ELISAs.ResultsOverall, E. canis, E. chaffeensis and E. ewingii seroprevalence was 0.8%, 2.8%, and 5.1%, respectively. The highest E. canis seroprevalence (2.3%) was found in a region encompassing Arkansas, Louisiana, Oklahoma, Tennessee and Texas. E. chaffeensis seroreactivity was 6.6% in the central region (Arkansas, Kansas, Missouri, and Oklahoma) and 4.6% in the southeast region (Georgia, Maryland, North Carolina, South Carolina, Tennessee and Virginia). Seroreactivity to E. ewingii was also highest in the central region (14.6%) followed by the southeast region (5.9%). The geospatial pattern derived from E. chaffeensis and E. ewingii seropositive samples was similar to previous reports based on E. chaffeensis seroreactivity in white-tailed deer and the distribution of human monocytic ehrlichiosis (HME) cases reported by the CDC.ConclusionsThe results of this study provide the first large scale regional documentation of exposure to E. canis, E. chaffeensis and E. ewingii in pet dogs, highlighting regional differences in seroprevalence and providing the basis for heightened awareness of these emerging vector-borne pathogens by veterinarians and public health agencies.
The Hemavet 950 and Heska CBC-Diff performed best of the 4 analyzers we compared. HCT, WBC, and platelet counts on the LaserCyte had minimally sufficient comparability for diagnostic use. Except for neutrophils (granulocytes), leukocyte differential counts were unreliable on all in-office analyzers. Instruments with a 5-part leukocyte differential provided no added benefit over a 3-part differential. Assessment of erythrocyte regeneration on the LaserCyte and VetAutoread was unreliable compared with the ADVIA 120.
The objective of this study was to investigate the effect of the degree and duration of early dietary AA restrictions on subsequent and overall pig performance and physical and sensory characteristics of pork. For the grower (G) and finisher-1 (F1) phases, 3 corn-soybean meal diets were formulated to contain 100, 80, or 60% of the 1998 NRC total Lys recommendations (100G, 80G, or 60G, and 100F1, 80F1, or 60F1, for the G and F1 phases, respectively). For the finisher-2 (F2) phase, a common corn-soybean meal diet was formulated to satisfy the 1998 NRC total Lys recommendation. Thirty gilts and 30 castrated males (2 gilts or 2 castrated males/pen) were randomly assigned to 5 dietary treatments (100G-100F1, 80G-100F1, 80G-80F1, 60G-100F1, and 60G-60F1) when BW was 22.7 +/- 0.3 kg. Pigs were switched to F1 and F2 diets at 50.7 +/- 0.4 and 79.9 +/- 0.5 kg of BW, respectively. Pigs had ad libitum access to feed and water. All pigs were slaughtered at 110.7 +/- 0.5 kg of BW, and LM samples were collected. Pigs fed the 60G diet had less (P < or = 0.05) ADG during the G phase and greater (P < or = 0.05) ultrasound backfat (UBF) at the end of the G phase than those fed the 100G diet. The ADG decreased linearly (R(2) = 0.70; P < 0.001) as the degree of AA restrictions became more severe. Although serum total protein (TP) and albumin concentrations in pigs fed the 60G-100F1 diets were less (P < or = 0.05) than those fed the 100G-100F1 diets at the end of the G phase, TP concentration was similar between the 2 groups at the end of the F1 phase. Likewise, ADG during the F1 phase and UBF at the end of the F1 phase in pigs fed the 60G-100F1 diets were similar to those fed the 100G-100F1 diets. Feeding the 80G diet resulted in numerically decreased ADG during the G phase, but there was no difference in ADG during the F1 and F2 phases or UBF at the end of F1 and F2 phases between pigs fed the 80G and 100G diets. Overall, pigs fed the 80G-80F1 diets had similar ADG, but less (P < or = 0.05) fat-free lean gain (LG) than those fed the 100G-100F1 diets. These pigs also had less (P < or = 0.05) serum TP and albumin concentrations than pigs fed the 100G-100F1 diets throughout the study. Pigs fed the 60G-60F1 diets had less (P < or = 0.05) overall ADG and G:F and less (P < or = 0.05) LM area and LG than those fed the 100G-100F1 diets. However, they had a greater (P < or = 0.05) subjective marbling score than those fed the 100G-100F1 diets. The results indicated that pigs fed the 80G-80F1 diets may have exhibited compensatory growth in BW gain, but not in terms of lean accretion. Growth performance and carcass traits of pigs fed the 60G-60F1 diets were reduced, indicating that the restriction may have been too severe or too long or both. Early dietary AA restrictions had no clear effect on physical and sensory characteristics of pork.
. Effect of early dietary amino acid restrictions on serum metabolites in pigs selected for lean growth efficiency. Can J. Anim. Sci. 86: 489-500. Thirty-two select line pigs for lean growth efficiency and 32 control line pigs (average 20 kg) were used in each of the two experiments to assess the effect of dietary amino acid restrictions during the grower phase on serum cholesterol, triglycerides, total protein, albumin, and glucose concentrations. In each experiment, 16 pens with two gilts and 16 pens with two castrated males per pen were assigned within the genetic line to grower (6.1 or 11.1 g lysine kg -1 ) and finisher diets (6.1 or 8.9 g lysine kg -1 ) in a 2 × 2 × 2 factorial arrangement in exp. 1, or grower diets (5.0, 7.0, 9.0, or 11.0 g lysine kg -1 ) in a 2 × 4 factorial arrangement of treatments in exp. 2. Pigs were offered common finisher diets in exp. 2. Serial blood samples were collected in both experiments. Serum cholesterol at the end of the grower phase was greater in the select line pigs in exp. 1 (P = 0.009) and pigs fed diets low in amino acids in exp. 2 (P = 0.005, 0.026, and 0.039 for linear, quadratic, and cubic, respectively). Serum cholesterol was correlated negatively with lysine intake (r = -0.38; P = 0.039) and serum urea nitrogen (r = -0.39; P = 0.032) in exp. 1 and positively with ultrasound backfat (r = 0.78; P = 0.001) in exp. 2. Serum cholesterol, however, may not reflect the cholesterol content of tissues or pork, except liver. At the end of the grower phase, pigs fed grower diets high in amino acids had greater serum total protein in exp. 2 (P = 0.040 and 0.093 for linear and quadratic, respectively) and albumin concentrations in exp. 1 (P = 0.001) and exp. 2 (linear, P = 0.001), and, at the end of the finisher phase, they had greater serum albumin in exp. 1 (P = 0.001) and seemed to have more total protein in exp. 2, even though there was a trend for the grower diet × genotype interaction (P = 0.095). The carryover effects of the grower diet during the realimentation phase seem to be contrary to the expected positive metabolite status of pigs exhibiting compensatory growth after a period of early dietary amino acid restrictions. On the other hand, higher serum total protein in exp. 2 (P = 0.041 and 0.001 at the end of the grower and finisher phases, respectively) and albumin concentrations at the end of the finisher phase in exp. 1 (P = 0.016) and exp. 2 (P = 0.059) in pigs selected for lean growth efficiency may be an indication that pigs utilized amino acids more efficiently for growth and protein accretion. Exploring fully the effect of dietary manipulations and genotypes on serum metabolites is obviously important, and the results of the present research may contribute to the development of the environmentally friendly, optimal feeding strategies for successful and sustainable pig production. Key words: Amino acid restrictions, genotypes, pigs, serum metabolitesMule, H. R., Chiba, L. I., Fabian, J., Kuhlers, D. L., Jungst, S. B., Frobish, L. T., Nadarajah, K., Bergen, W....
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.